DK192389A - Rekombinant gag-precursor, vaccine indeholdende en saadan precursor, fremgangsmaade til rensning af en saadan precursor og fremgangsmaade til opnaaelse af et vandoploeseligt produkt heraf - Google Patents

Rekombinant gag-precursor, vaccine indeholdende en saadan precursor, fremgangsmaade til rensning af en saadan precursor og fremgangsmaade til opnaaelse af et vandoploeseligt produkt heraf

Info

Publication number
DK192389A
DK192389A DK192389A DK192389A DK192389A DK 192389 A DK192389 A DK 192389A DK 192389 A DK192389 A DK 192389A DK 192389 A DK192389 A DK 192389A DK 192389 A DK192389 A DK 192389A
Authority
DK
Denmark
Prior art keywords
precursor
procedure
purchase
cleaning
water soluble
Prior art date
Application number
DK192389A
Other languages
Danish (da)
English (en)
Other versions
DK192389D0 (da
Inventor
George Phillip Vlasuk
Mark A Polokoff
Richard A F Dixon
Kathryn J Hofmann
Loren D Schultz
Melvin Silberklang
Ronald W Ellis
Emilio A Emini
Robert J Gerety
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK192389D0 publication Critical patent/DK192389D0/da
Publication of DK192389A publication Critical patent/DK192389A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK192389A 1988-04-25 1989-04-20 Rekombinant gag-precursor, vaccine indeholdende en saadan precursor, fremgangsmaade til rensning af en saadan precursor og fremgangsmaade til opnaaelse af et vandoploeseligt produkt heraf DK192389A (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US18562688A 1988-04-25 1988-04-25
US18557288A 1988-04-25 1988-04-25
US18571188A 1988-04-25 1988-04-25
US28214488A 1988-12-09 1988-12-09
US28214688A 1988-12-09 1988-12-09
US28214588A 1988-12-09 1988-12-09

Publications (2)

Publication Number Publication Date
DK192389D0 DK192389D0 (da) 1989-04-20
DK192389A true DK192389A (da) 1989-10-26

Family

ID=27558760

Family Applications (1)

Application Number Title Priority Date Filing Date
DK192389A DK192389A (da) 1988-04-25 1989-04-20 Rekombinant gag-precursor, vaccine indeholdende en saadan precursor, fremgangsmaade til rensning af en saadan precursor og fremgangsmaade til opnaaelse af et vandoploeseligt produkt heraf

Country Status (8)

Country Link
EP (1) EP0340837A1 (xx)
JP (1) JPH0213391A (xx)
AU (1) AU3335689A (xx)
DK (1) DK192389A (xx)
FI (1) FI891917A (xx)
IL (1) IL90048A0 (xx)
NO (1) NO891691L (xx)
PT (1) PT90354A (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP129A (en) * 1988-06-03 1991-04-17 Smithkline Biologicals S A Expression of retrovirus gag protein eukaryotic cells
ATE199394T1 (de) * 1992-06-04 2001-03-15 Univ Osaka Res Found Gag-env fusion-antigen aus hiv
US20050112139A1 (en) * 2003-10-23 2005-05-26 Nmk Research, Llc Immunogenic composition and method of developing a vaccine based on factor H binding sites
JP6199533B2 (ja) 2006-07-13 2017-09-20 インスティチュート フォー アドバンスド スタディ ウイルス阻害性ヌクレオチド配列およびワクチン

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6713287A (en) * 1986-01-06 1987-07-09 F. Hoffmann-La Roche & Co. Expression of htlv-iii gag-gene
NZ221440A (en) * 1986-08-20 1991-11-26 Genetic Systems Corp Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
IL84154A0 (en) * 1986-10-16 1988-03-31 Microgenesys Inc Polypeptides derived from the envelope gene of human immunodeficiency virus in recombinant baculovirus infected insect cells and vaccines against acquired immune deficiency syndrome containing the same

Also Published As

Publication number Publication date
FI891917A0 (fi) 1989-04-21
NO891691L (no) 1989-10-26
AU3335689A (en) 1989-11-23
DK192389D0 (da) 1989-04-20
PT90354A (pt) 1989-11-10
FI891917A (fi) 1989-10-26
JPH0213391A (ja) 1990-01-17
IL90048A0 (en) 1989-12-15
EP0340837A1 (en) 1989-11-08
NO891691D0 (no) 1989-04-24

Similar Documents

Publication Publication Date Title
NO891351D0 (no) Flytende rensemiddelblanding og fremgangsmaate for fremstilling av denne.
NO871693L (no) Varmformpresset produkt og fremgangsmaate for varmformpressing.
NO893896L (no) Farmasoeytiske formuleringer og fremgangsmaate for fremstilling av disse.
DK51493A (da) Laegemiddel indeholdende humant interleukin-1alfa og anvendelse af interleukin-1alfa til fremstilling af et saadant laegemiddel
NO875259L (no) Fremgangsmaate og anordning for fremstilling av syntesegass
DK377987A (da) Fremgangsmaade og struktur til dannelse af et reaktionsprodukt
DK560289A (da) Fluoxetin-analoge, fremgangsmaade til fremstilling heraf og farmaceutiske midler indeholdende saadanne
DK192389A (da) Rekombinant gag-precursor, vaccine indeholdende en saadan precursor, fremgangsmaade til rensning af en saadan precursor og fremgangsmaade til opnaaelse af et vandoploeseligt produkt heraf
DK455986A (da) Ostelignende produkt fremgangsmaade til dets fremstilling og anvendelse heraf
NO171045C (no) Anordning og fremgangsmaate for fremstilling av syntesegass
DK129593D0 (da) Fremgangsmaade og anlaeg til fremstilling af et vandoploeseligt, jernfattigt proteinprodukt ud fra et blodcelleholdigt raamateriale samt et vandoploeseligt proteinmateriale
NO891630D0 (no) Fremgangsmaate og anordning for fremstilling av diafragmer.
DK701588A (da) N-hydroxy-5-phenyl-2-furancarboximidamider og anvendelse heraf til fremstilling af farmceutiske praeparater
DK61288A (da) Fremgangsmaade til fremstilling af et granulatformet detergentenzymprodukt, anvendelse af et saadant produkt og detergent, der indeholder et saadant produkt
NO882965D0 (no) Isotermisk fremgangsmaate for fremstilling av poroese metall-andre fase-kompositter og derved oppnaadd poroest produkt.
NO884818D0 (no) Fremgangsmaate og mellomprodukter for fremstilling av halogenerte proteasehemmere.
NO883987L (no) Fremgangsmaate for fremstilling av n-(substituert aklyliden) kondensert bicykloalkyliden og anvendelse derav som medikamenter.
DK670588D0 (da) Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet
DK448989A (da) Fremgangsmaade og anlaeg til fremstilling af et produkt til anvendelse som dyrkningsunderlag
NO892670D0 (no) Gassrensemasser og fremgangsmaate for deres fremstilling.
DK684487A (da) Farmaceutisk praeparat og anvendelse af enkephalinase til fremstilling af et laegemiddel
NO874697D0 (no) Fremgangsmaate og anordning for granulering og granulert produkt.
NO900808L (no) Fremgangsmaate og anordning for fremstilling av plasmider og kosmider.
NO893458L (no) Fremgangsmaate og kakalysator for fremstilling av syntesegass.
DK394989D0 (da) Purinforbindelse, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende en saadan forbindelse